Woodland International Research recapitalized by DFW Capital Partners

Apr. 2014

Client: Woodland is a leading clinical pharmacology and research services company focused on psychiatric indications in two facilities in Arkansas

Role: Edgemont Partners acted as exclusive financial advisor to Woodland in its recapitalization and merger to form Evolution Research Group sponsored by DFW Capital

Location: Little Rock, AR

Sector: Pharmaceutical Services

Lead Banker: David Blume